Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:36 pm Purchase | 2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management, LLC | 626,862 9.990% | 61,378 (+10.85%) | Filing History |
| 2024-11-13 5:35 pm Unchanged | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management, LLC | 372,797 9.990% | 0 (Unchanged) | Filing History |
| 2024-11-13 5:34 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Stonepine Capital Management, LLC | 307,229 9.990% | 307,229 (New Position) | Filing History |
| 2024-11-13 5:32 pm Sale | 2024-09-30 | 13G | CalciMedica, Inc. CALC | Stonepine Capital Management, LLC | 0 0.000% | -1,045,204 (Position Closed) | Filing History |
| 2024-11-13 5:31 pm Sale | 2024-09-30 | 13G | Rezolute, Inc. RZLT | Stonepine Capital Management, LLC | 0 0.000% | -2,768,656 (Position Closed) | Filing History |
| 2024-11-13 5:30 pm Sale | 2024-09-30 | 13G | IO Biotech, Inc. IOBT | Stonepine Capital Management, LLC | 0 0.000% | -3,641,345 (Position Closed) | Filing History |
| 2024-11-13 5:29 pm Sale | 2024-09-30 | 13G | Alimera Sciences, Inc. ALIM | Stonepine Capital Management, LLC | 0 0.000% | -5,373,732 (Position Closed) | Filing History |
| 2024-10-29 5:12 pm Purchase | 2024-10-23 | 13G | TELA Bio, Inc. TELA | Stonepine Capital Management, LLC | 2,831,839 7.700% | 2,831,839 (New Position) | Filing History |
| 2024-10-10 4:07 pm Purchase | 2024-10-07 | 13G | Aprea Therapeutics, Inc. APRE | Stonepine Capital Management, LLC | 365,436 6.600% | 365,436 (New Position) | Filing History |
| 2024-08-15 4:19 pm Purchase | 2024-08-06 | 13G | Tenax Therapeutics, Inc. TENX | Stonepine Capital Management, LLC | 372,797 9.990% | 372,797 (New Position) | Filing History |
| 2024-07-29 4:04 pm Purchase | 2024-07-24 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management, LLC | 2,666,666 6.700% | 2,666,666 (New Position) | Filing History |
| 2024-04-19 4:34 pm Purchase | 2024-04-01 | 13G | Surrozen, Inc. SRZN | Stonepine Capital Management, LLC | 199,158 6.000% | 199,158 (New Position) | Filing History |
| 2024-02-14 10:01 am Sale | 2023-12-31 | 13G | UroGen Pharma Ltd. URGN | Stonepine Capital Management, LLC | 0 0.000% | -1,304,947 (Position Closed) | Filing History |
| 2024-02-13 4:35 pm Sale | 2023-12-31 | 13G | Exagen Inc. XGN | Stonepine Capital Management, LLC | 669,684 3.900% | -184,358 (-21.59%) | Filing History |
| 2024-02-13 4:34 pm Sale | 2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | Stonepine Capital Management, LLC | 5,937,000 4.300% | -5,258,189 (-46.97%) | Filing History |
| 2024-02-13 4:33 pm Sale | 2023-12-31 | 13G | Third Harmonic Bio, Inc. THRD | Stonepine Capital Management, LLC | 0 0.000% | -2,152,968 (Position Closed) | Filing History |
| 2024-02-13 4:32 pm Sale | 2023-12-31 | 13G | SCYNEXIS, Inc. SCYX | Stonepine Capital Management, LLC | 1,355,186 3.600% | -1,422,691 (-51.22%) | Filing History |
| 2024-02-13 4:31 pm Sale | 2023-12-31 | 13G | Rezolute, Inc. RZLT | Stonepine Capital Management, LLC | 2,768,656 7.000% | -252,848 (-8.37%) | Filing History |
| 2024-02-13 4:30 pm Sale | 2023-12-31 | 13G | aTyr Pharma, Inc. ATYR | Stonepine Capital Management, LLC | 482,258 0.800% | -4,087,175 (-89.45%) | Filing History |
| 2024-02-13 4:29 pm Sale | 2023-12-31 | 13G | IO Biotech, Inc. IOBT | Stonepine Capital Management, LLC | 3,641,345 5.400% | -309,271 (-7.83%) | Filing History |